Synexus Recruits 37% of Patients at 7 Sites for Global Hypertension Study

Mon Jul 13, 2009 5:12am EDT
 
[-] Text [+]
MANCHESTER, England--(Business Wire)--
Synexus, based in Manchester, UK, has once again recruited the highest number of
patients for a major global study. Following fast from its recent JUPITER
success, Synexus has this time, recruited 1221 patients at seven UK sites,
averaging 174 patients per site for a hypertension study. A total of 3273
patients were recruited worldwide at 87 sites. 

Professor Neil Poulter, Chair of Preventive Cardiovascular Medicine at Imperial
College, London, and in charge of the hypertension study, recognises the
benefits of Synexus dedicated trial sites and innovative patient recruitment
strategies: "Working with Synexus has made a genuine difference to the cost
effectiveness of the overall trial because of the speed with which we were able
to recruit into the study. The proactive patient recruitment procedures Synexus
use, together with their dedicated teams, streamlined so much of what can often
be a laborious and ineffective process." 

Commenting on Synexus role in this major study, Michael Fort, CEO said:
"Following on from our success with JUPITER this demonstrates that our methods
consistently deliver excellent results for our clients, including fast and
reliable patient recruitment and the resulting cost efficiencies we are able to
achieve." 

- ends - 

Synexus background

Synexus headquartered in Manchester, England, is the world`s largest
multi-national company dedicated to the recruitment of clinical trials at its
own research centres across the globe on behalf of its pharmaceutical, biotech
and CRO clients. 

Synexus has 16 research centres across the UK, Poland, Hungary, Bulgaria, India
and South Africa staffed by full time GCP trained investigators. 

Synexus currently has more than twelve thousand patients enrolled in clinical
trials. 





Vane Percy & Roberts
Simon Vane Percy
Office: +44 (0) 1737 821 890/892
Mobile: +44 (0) 7710 005910
Home: +44 (0) 1883 724505
(e) simon@vanepercy.com



Copyright Business Wire 2009

 

Featured Broker sponsored link

Editor's Choice

A selection of our best photos from the past 24 hours.   Slideshow 

Most Popular on Reuters

  • Articles
  • Video